AstraZeneca Pharma India declined 5.36% over the past week and gained 3.27% over the past month. Year-to-date, it fell 29.76%. Drugmaker AstraZeneca Pharma India Ltd on Tuesday, November 17, said that it has signed a Letter of Intent (LoI) with Reliance Industries subsidiary Strand Life Sciences, which is a genomics research and diagnostics company, to explore opportunities to collaborate in healthcare in India, the company said in an exchange filing.